Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252313114 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Raja Gopal Reddy Mooli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Liver Cirrhosis, Hepatocytes, Apoptosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
The activation of hypoxia-inducible factors (HIF)-1α and 2α in the liver is closely linked to the progression of fatty liver diseases. Prior studies indicated that disrupting hepatocyte HIF-2α attenuates diet-induced hepatic steatosis, subsequently decreasing fibrosis. However, the direct role of hepatocyte HIF-2α in liver fibrosis has not been addressed. Hepatic HIF-2α expression was examined in mouse model of carbon tetrachloride (CCl4)-induced liver fibrosis. Conditional hepatocyte Hif-2α knockout mice were employed to investigate the role of hepatocyte HIF-2α in fibrosis. Markers of apoptosis, proliferation, inflammation, and fibrosis were assessed through biochemical, molecular, and histological analyses. We found an induction of HIF-2α in CCL4-injected liver injury and fibrosis mouse models. Hepatocyte-specific deletion of HIF-2α attenuated stellate cell activation and fibrosis, with no significant difference in inflammation. Disrupting hepatocyte HIF-2α led to reduced injury-mediated hepatocellular apoptosis. Surviving hepatocytes exhibited hypertrophy, which was strongly associated with the activation of c-JUN signaling. Our study demonstrates a direct role of hepatocyte HIF-2α in liver fibrosis by promoting hepatocyte apoptosis. The reduction in apoptosis and induction of hepatocyte hypertrophy following HIF-2α disruption is closely linked to enhanced c-JUN signaling, a survival mechanism in response to liver injury. These findings highlight HIF-2α as a potential therapeutic target for liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Division of Experimental Pathology, Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15261, USA.
ORCID-Profile: Mikayla Watt, Nikita K Gandhi
Förderung
- NIDDK NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Mooli, R. G. R., Mukhi, D., Watt, M., Nagati, V., Reed, S. M., Gandhi, N. K., Oertel, M., & Ramakrishnan, S. K. (2024). Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313114
Vancouver
Mooli RGR, Mukhi D, Watt M, Nagati V, Reed SM, Gandhi NK, et al. Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313114
BibTeX
@article{Mooli2024,
author = {Mooli, Raja Gopal Reddy and Mukhi, Dhanunjay and Watt, Mikayla and Nagati, Veerababu and Reed, Sara M and Gandhi, Nikita K and Oertel, Michael and Ramakrishnan, Sadeesh K},
title = {Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252313114}
}
EUVIMED